Laurel Wealth Advisors, Inc. Bausch Health Companies Inc. Transaction History

Laurel Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.06 - $23.63 $135,128 - $452,278	-19,140 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$21.6 - $27.79 $19,288 - $24,816	-893 Reduced 4.46%	19,140 $437,000
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $460,759 - $581,157	20,033 New	20,033 $553,000
Q4 2018 Feb 13, 2019	SELL	$17.64 - $28.32 $173,754 - $278,952	-9,850 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$20.64 - $25.67 $203,304 - $252,849	9,850 New	9,850 $252,000

254

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.69B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.